A detailed history of Lindbrook Capital, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 116 shares of PRCT stock, worth $8,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares
116
Previous 89 30.34%
Holding current value
$8,410
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$56.31 - $84.99 $1,520 - $2,294
27 Added 30.34%
116 $9,000
Q2 2024

Jul 31, 2024

BUY
$45.73 - $69.19 $685 - $1,037
15 Added 20.27%
89 $5,000
Q4 2023

Jan 31, 2024

BUY
$24.89 - $43.41 $448 - $781
18 Added 32.14%
74 $3,000
Q3 2023

Oct 25, 2023

BUY
$30.02 - $38.81 $180 - $232
6 Added 12.0%
56 $1,000
Q2 2023

Jul 28, 2023

BUY
$26.7 - $37.02 $1,335 - $1,851
50 New
50 $1,000
Q4 2022

Jan 24, 2023

BUY
$38.78 - $46.78 $1,047 - $1,263
27 New
27 $0

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.23B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.